A detailed history of Atlas Legacy Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Atlas Legacy Advisors, LLC holds 4,101 shares of JNJ stock, worth $818,477. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,101
Previous 2,735 49.95%
Holding current value
$818,477
Previous $418 Million 82.02%
% of portfolio
0.15%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

BUY
$155.17 - $185.42 $211,962 - $253,283
1,366 Added 49.95%
4,101 $760 Million
Q2 2025

Aug 06, 2025

BUY
$146.36 - $159.82 $67,764 - $73,996
463 Added 20.38%
2,735 $418 Million
Q1 2025

May 07, 2025

BUY
$142.06 - $167.7 $76,002 - $89,719
535 Added 30.8%
2,272 $377 Million
Q4 2024

Jan 31, 2025

BUY
$143.34 - $165.86 $248,981 - $288,098
1,737 New
1,737 $251 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Atlas Legacy Advisors, LLC Portfolio

Follow Atlas Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Legacy Advisors, LLC with notifications on news.